These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5316651)

  • 1. [Clinical evaluation of Cinnarizine in patients with peripheral vascular diseases].
    Simões Neto E
    Hospital (Rio J); 1971 Jan; 79(1):189-98. PubMed ID: 5316651
    [No Abstract]   [Full Text] [Related]  

  • 2. [Flunarizine in patients with inadequate cerebral and peripheral circulation. Multicentric double blind study].
    Domschky K; Nelson M; Dammhayn B; Terjung E
    Med Welt; 1977 Jun; 28(23):1062-4. PubMed ID: 886963
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of MD 1035 in peripheral vascular manifestations].
    Barraine R; Efthymiou TP; Marcantoni JP
    Presse Med (1893); 1970 Dec; 78(53):2389-90. PubMed ID: 5489156
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trial of cinnarizine in some vascular diseases].
    Triandaf I; Cosma M; Triandaf N
    Rev Med Chir Soc Med Nat Iasi; 1976; 80(1):19-22. PubMed ID: 135327
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary results in the treatment of peripheral arteriopathies with a new pharmacologic substance: I-(2"pyrimidyl)4 piperonyl piperazine (ET 495).
    Royer RJ
    Bibl Cardiol; 1969; 26():174-9. PubMed ID: 5402343
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of nicergoline in peripheral arteriopathies of the lower limbs. Double-blind study].
    Coscia M
    Minerva Cardioangiol; 1972 Sep; 20(9):497-504. PubMed ID: 4561065
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of dioxylline phosphate in vascular diseases. Clinical results].
    Rodari T; Tirella G
    Clin Ter; 1972 Jul; 62(1):53-7. PubMed ID: 5071748
    [No Abstract]   [Full Text] [Related]  

  • 8. [The therapeutic effects of flunarizine in peripheral arterial diseases and cerebrovascular diseases].
    De Gregorio G; Restivo S
    Clin Ter; 1982 Dec; 103(5):501-7. PubMed ID: 7160142
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of cinnarizine in patients with cerebral circulatory deficiency.
    Toledo JB; Pisa H; Marchese M
    Arzneimittelforschung; 1972 Feb; 22(2):448-51. PubMed ID: 4554633
    [No Abstract]   [Full Text] [Related]  

  • 10. Cinnarizine in peripheral vascular insufficiency. Studies on blood flow, muscle capacity, and vascular tone.
    Schuermans V; Boermans A; Geivers H; Jageneau A; Brugmans J
    Arzneimittelforschung; 1971 Oct; 21(10):1541-3. PubMed ID: 5171882
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rheologic therapy of peripheral arteriopathies. Personal observations on the use of flunarizin].
    Palleschi M; Marci M; Ceraso C; Passacantilli A; Marin P
    Clin Ter; 1984 Aug; 110(3):215-20. PubMed ID: 6237860
    [No Abstract]   [Full Text] [Related]  

  • 12. Peripheral vascular disease: cinnarizine et al.
    Drug Ther Bull; 1981 Mar; 19(7):27-8. PubMed ID: 7227205
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic use of flunarizine in the treatment arteriopathies of the lower extremities].
    Ambrosi V; Gabrielli F
    Minerva Med; 1983 Mar; 74(13):685-9. PubMed ID: 6220230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of peripheral vascular disorders with dilatol].
    Knapik Z; Twardzicki J; Wlodarczykowa J
    Pol Tyg Lek; 1965 Jun; 20(23):846-8. PubMed ID: 5841123
    [No Abstract]   [Full Text] [Related]  

  • 15. Responsiveness of various symptoms of vascular disorders to calcium antagonist.
    Verhaegen H; Reyntjens A; Horig C; Pötsch W
    Angiology; 1979 Jul; 30(7):447-53. PubMed ID: 380409
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical considerations on the use of a drug with vasodilating hemokinetic action in cerebral and peripheral vascular diseases].
    Florio F; Ruffolo S; Piro E
    Minerva Cardioangiol; 1976 Feb; 24(2):161-70. PubMed ID: 1256656
    [No Abstract]   [Full Text] [Related]  

  • 17. [Our experience in the treatment of peripheral vascular diseases with raubasine].
    Vercellio G; Costantini S; Giulini S
    Minerva Cardioangiol; 1972 Apr; 20(4):217-30. PubMed ID: 5023726
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relationship between blood flow values of the upper and the lower extremities and effects of a vasoactive agent in persons with normal circulation and patients with vascular diseases].
    Caesar K
    Med Welt; 1971 Apr; 14():559-62. PubMed ID: 5551942
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical results in therapy of peripheral vascular diseases with ginkgo-biloba].
    Bartolo M
    Minerva Med; 1973 Nov; 64(79 Suppl):4187-93. PubMed ID: 4592295
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experiences with a new vasodilator: 3-(methylhydroxyethylamino)-2-hydroxypropyltheophylline nicotinate].
    Sideri GC; Fumagalli G; Locatelli R
    Arch Patol Clin Med; 1965 Jun; 41(6):479-83. PubMed ID: 5319767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.